Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Allaw MB, Switchenko JM, Khalil L, Wu C, et al. Oncology 2022;100:131-139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Allaw MB, Switchenko JM, Khalil L, Wu C, et al. Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors. Oncology 2022;100:131-139.
PMID: 35078191